You are here

A Study of Ziprasidone for the Treatment of Psychosis in Patients Who Had Already Had Benefits From Ziprasidone Treatment in a Previous Study

Last updated on February 22, 2019

FOR MORE INFORMATION
Study Location
Pfizer Investigational Site
Salvador, Bahia, 41180-000 Brazil
Contact
1-800-718-1021
Eligibility criteria
Condition
The disease, disorder, syndrome, illness, or injury that is being studied.
Pyschotic Disorders
Sex
Females and Males
Age
Pediatric Trials: 0-17 Years
Adult Trials: 18+ Years
18-55 years
Inclusion criteria
The factors, or reasons, that allow a person to participate in a clinical study.
Show details

- Psychotic disorder

- Completion of previous study of intramuscular ziprasidone

- Ability to continue with oral ziprasidone

Exclusion criteria
The factors, or reasons, that prevent a person from participating in a clinical study.
Show details

- Concomitant treatment with other anti-psychotic agents within 12 hours prior to the
enrollment; for depot agents, a period of two weeks or a cycle, whichever is longer,
should occur between the last administration and the patient's enrollment.

- Treatment with antidepressants or mood stabilizers within seven days prior to the
enrollment; for MAOIs (monoamine oxidase inhibitors) and moclobemide, this period
should be of two weeks; for fluoxetine, five weeks.

- Resistance to conventional psychotic agents. (Resistance is defined as a failure to
present a therapeutic response during the acute exacerbation after proper attempts of
treatment with marketed antipsychotic agents in two or more occasions during the two
years prior to the enrollment in the study.)

NCT00645320
Pfizer
Completed
A Study of Ziprasidone for the Treatment of Psychosis in Patients Who Had Already Had Benefits From Ziprasidone Treatment in a Previous Study

NEED INFO?

Questions about a trial? Call or email to reach a Pfizer Clinical Trial Contact Center

Pfizer Clinical Trials Contact Center

1-800-718-1021

[email protected]

call now

Try a new search

Search for Clinical Trials by condition, keyword or trial number. Share your location or enter your city or zip code to find studies near you.

Based on your search, you may also be interested in

FOR MORE INFORMATION

Contact a representative by phone, email, or visiting the study website. Please see the references below:

BY PHONE

Pfizer Clinical Trials Contact Center

1-800-718-1021

BY EMAIL

Contact

[email protected]

Call Now